These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19342503)

  • 1. Newborn screening for sickle cell disease through use of tandem mass spectrometry.
    Turner C; Daniel Y; Dalton RN
    Clin Chem; 2009 Jun; 55(6):1243-4; author reply 1244-5. PubMed ID: 19342503
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.
    Lobitz S; Frömmel C; Brose A; Blankenstein O; Turner C; Dalton RN; Daniel Y; Klein J
    Ann Hematol; 2022 Aug; 101(8):1859-1860. PubMed ID: 35293609
    [No Abstract]   [Full Text] [Related]  

  • 3. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for sickle cell disorders using tandem mass spectrometry: three years' experience of using a protocol to detect only the disease states.
    Moat SJ; Rees D; George RS; King L; Dodd A; Ifederu A; Ramgoolam T; Hillier S
    Ann Clin Biochem; 2017 Sep; 54(5):601-611. PubMed ID: 28656815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for sickling and other haemoglobin disorders using tandem mass spectrometry: A pilot study of methodology in laboratories in England.
    Daniel YA; Henthorn J
    J Med Screen; 2016 Dec; 23(4):175-178. PubMed ID: 26965059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
    Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
    Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Newborn screening for sickle cell anemia].
    Dulín-Iñiguez E
    Med Clin (Barc); 2006 Mar; 126(8):293-4. PubMed ID: 16527156
    [No Abstract]   [Full Text] [Related]  

  • 8. [Selective neonatal screening for sickle cell disease].
    González Santiago P; Ruiz-Alvarez M; Arribas Gómez I; Vecilla Rivelles MC; Aracil Santos FJ
    An Pediatr (Barc); 2008 Apr; 68(4):407-8. PubMed ID: 18394393
    [No Abstract]   [Full Text] [Related]  

  • 9. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Lobitz S; Klein J; Brose A; Blankenstein O; Frömmel C
    Ann Hematol; 2019 Jan; 98(1):47-53. PubMed ID: 30132072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neonatal screening of sickle cell anemia in metropolitan France].
    Bardakjian J; Benkerrou M; Bernaudin F; Briard ML; Ducrocq R; Lambilliotte A; Léna-Russo D; de Montalembert M; Thuret I; Bégué P; Elion J; Galactéros F;
    Arch Pediatr; 2000 Dec; 7(12):1261-3. PubMed ID: 11147058
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics: Newborn screening for sickle cell anemia.
    Meschino WS; Gibbons CA; Allanson J; Blaine SM; Cremin C; Dorman H; Honeywell C; Permaul J; Wilson BJ; Carroll JC
    Can Fam Physician; 2009 Oct; 55(10):1001. PubMed ID: 19826159
    [No Abstract]   [Full Text] [Related]  

  • 12. Sickle-cell disease not identified by newborn screening because of prior transfusion.
    Reed W; Lane PA; Lorey F; Bojanowski J; Glass M; Louie RR; Lubin BH; Vichinsky EP
    J Pediatr; 2000 Feb; 136(2):248-50. PubMed ID: 10657834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evidence for the widespread use of neonatal screening for sickle cell disease].
    Cavazzana M; Stanislas A; Rémus C; Duwez P; Renoult J; Cretet J; Fernandes S; Le Mée C; Allaf B; Porquet D; Munnich A; Polak M; Gauthereau V; Girot R
    Med Sci (Paris); 2018 Apr; 34(4):309-311. PubMed ID: 29658472
    [No Abstract]   [Full Text] [Related]  

  • 14. Newborn metabolic screening and related pitfalls.
    Eddy M; Gottesman GS
    Mo Med; 2009; 106(3):234-40. PubMed ID: 22641920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for sickle cell disease in newborns.
    Lin KW
    Am Fam Physician; 2009 Mar; 79(6):507-8. PubMed ID: 19323364
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of neonatal screening for sickle cell disease.
    Lane PA; Eckman JR
    J Pediatr; 1992 Jan; 120(1):162-3. PubMed ID: 1731017
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neonatal screening for sickle cell disease].
    Farriaux JP
    Ann Biol Clin (Paris); 2003; 61(4):376-8. PubMed ID: 12915346
    [No Abstract]   [Full Text] [Related]  

  • 18. Newborn Screening for Sickle Cell Disease.
    Erhabor GE
    West Afr J Med; 2023 Mar; 40(3):237-238. PubMed ID: 37011409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neonatal screening for sickle cell anemia and other hemoglobinopathies in Martinique].
    Brunod M
    Med Trop (Mars); 1999; 59(4):412. PubMed ID: 10816758
    [No Abstract]   [Full Text] [Related]  

  • 20. Newborn screening for sickle cell disease in Africa.
    Makoni M
    Lancet Haematol; 2021 Jul; 8(7):e476. PubMed ID: 34171276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.